PO.ET05.01 · 实验与分子治疗

Per and polyfluoroalkyl substances (PFAS) promote proliferation and migration in genetically distinct kidney cancer cell lines

海报缩略图:Per and polyfluoroalkyl substances (PFAS) promote proliferation and migration in genetically distinct kidney cancer cell lines
编号 5691 展板 7 时间 4/21 02:00–05:00 区域 Section 12 主讲 RAKESH ARYA, PhD
分会场 Mechanisms of Anticancer Drug Action
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Rakesh Kumar Arya1, Mia Sand2, Sahab Ram Dewala1, Can Aydogdu3, Gabriela M. Diaz3, Christopher Weight3, Riccardo Autorino3, Abhishek Chakraborty4, Jacob M. Knorr3, Joseph M. K. Irudayaraj2, Laura Bukavina3

1Center for Immunotherapy and Precision Immuno-oncology, Cleveland Clinic Lerner Research Institute, Cleveland, OH,2Department of Bioengineering,, University of Illinois Urbana-Champaign, Champaign, IL,3Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH,4Department of Cancer Biology, Cleveland Clinic Research, Cleveland, OH

摘要 Abstract

Introduction and Objectives: Per- and polyfluoroalkyl substances (PFAS) such as GenX, PFOA, and PFOS are persistent environmental pollutants increasingly associated with renal carcinogenesis. Their direct effects on kidney cancer progression remain unclear. This study investigated whether PFAS exposure enhances proliferation and migration in two genetically distinct kidney cancer models-human RCC-ER (VHL-mutant) and murine Renca (VHL-wild type). Methods: RCC-ER and Renca cells were treated with GenX, PFOA, or PFOS at physiologically relevant concentrations (0.5-40 nM). Proliferation was monitored over 72 h using the IncuCyte S3 system. Migration was assessed in ImageLock plates, where wounds were created after 24 h and imaged every 1.5 h for 72 h. Wound closure was quantified by percentage wound closure (WC) and relative wound density (RWD) using IncuCyte software. All experiments were performed in triplicate to assess dose dependency and statistical significance. Results: PFAS exposure significantly enhanced both proliferation and migration in kidney cancer cells, with compound- and cell line-specific variations. RenCa cells exhibited strong proliferative responses to GenX and PFOS from 0.5-20 nM, peaking at 5 nM respectively, while PFOA showed cytotoxic effects at these doses. In contrast, RCC-ER cells demonstrated increased proliferation in response to PFOA (max at 40 nM) and PFOS (max at 5 nM), whereas GenX had minimal effect on proliferation at low doses. All three PFAS markedly accelerated wound closure and relative wound density in both cell lines, indicating enhanced migratory potential. Collectively, these data reveal that PFAS compounds augment pro-oncogenic behaviors across human and murine kidney cancer models. Conclusion: PFAS compounds promote proliferative and migratory phenotypes in both murine and human kidney cancer models through distinct but convergent metabolic mechanisms. The conserved effects across VHL-wild-type and VHL-mutant systems underscore PFAS as a potential environmental accelerator of renal tumor progression and justify further mechanistic and translational studies.
利益披露 Disclosure
R. K. Arya, None.. M. Sand, None.. S. Dewala, None.. C. Aydogdu, None.. G. M. Diaz, None.. C. Weight, None.. R. Autorino, None.. A. Chakraborty, None.. J. M. Knorr, None.. J. M. K. Irudayaraj, None.. L. Bukavina, None.

在会议检索中打开